Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHASE IV OPEN LABEL SINGLE GROUP ONE YEAR STUDY OF HOME SELF-INJECTION WITH SAYANA (REGISTERED) PRESS IN ADULT WOMEN OF REPRODUCTIVE AGE - A PRAGMATIC CLINICAL TRIAL

NCT03034057 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03034057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03034057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHASE IV OPEN LABEL SINGLE GROUP ONE YEAR STUDY OF HOME SELF-INJECTION WITH SAYANA (REGISTERED) PRESS IN ADULT WOMEN OF REPRODUCTIVE AGE - A PRAGMATIC CLINICAL TRIAL
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
August 23, 2017
Completion date
December 7, 2018
Enrollment
169 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

contraception